111111111 CENOTE PHARMA LIMITED | Parental, filial companies, and officers
logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 8
  • 1
    Condon, Richard Michael
    Born in August 1976
    Individual (11 offsprings)
    Officer
    2024-03-07 ~ now
    OF - Director → CIF 0
  • 2
    Buckley, Gary David
    Born in February 1986
    Individual (14 offsprings)
    Officer
    2024-03-07 ~ now
    OF - Director → CIF 0
  • 3
    Ranson, Paul
    Company Director born in January 1953
    Individual (13 offsprings)
    Officer
    2015-12-10 ~ 2024-03-07
    OF - Director → CIF 0
    Mr Paul Ranson
    Born in January 1953
    Individual (13 offsprings)
    Person with significant control
    2016-04-06 ~ 2020-07-29
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    Paul Ranson
    Born in January 1953
    Individual (13 offsprings)
    Person with significant control
    2023-07-18 ~ 2024-03-07
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 4
    Williams, Keith
    Director born in December 1971
    Individual (2 offsprings)
    Officer
    2022-01-01 ~ 2024-03-07
    OF - Director → CIF 0
    Mr Keith Williams
    Born in December 1971
    Individual (2 offsprings)
    Person with significant control
    2020-03-18 ~ 2024-03-07
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 5
    May, Jonathan Charles
    Born in April 1970
    Individual (16 offsprings)
    Officer
    2024-03-07 ~ now
    OF - Director → CIF 0
  • 6
    Close, Michael Stuart
    Director born in April 1971
    Individual (10 offsprings)
    Officer
    2022-01-01 ~ 2024-03-07
    OF - Director → CIF 0
    Mr Michael Stuart Close
    Born in April 1971
    Individual (10 offsprings)
    Person with significant control
    2020-07-29 ~ 2024-03-07
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 7
    MOONWISE LIMITED
    10236843
    12 Bridewell Place, Third Floor East, London, United Kingdom
    Dissolved Corporate (3 parents, 1 offspring)
    Person with significant control
    2019-08-20 ~ 2023-07-18
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 8
    ASPIRE PHARMA LIMITED
    06828501
    102, High Street, Godalming, Surrey, England
    Active Corporate (17 parents, 4 offsprings)
    Person with significant control
    2024-03-07 ~ now
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
parent relation
Company in focus

CENOTE PHARMA LIMITED

Period: 2015-12-10 ~ now
Company number: 09910964
Registered name
CENOTE PHARMA LIMITED - now
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Intangible Assets
0 GBP2024-12-31
2,511 GBP2024-03-06
Debtors
4,500 GBP2024-12-31
450,834 GBP2024-03-06
Cash at bank and in hand
0 GBP2024-12-31
63,344 GBP2024-03-06
Current Assets
4,500 GBP2024-12-31
758,060 GBP2024-03-06
Creditors
Current, Amounts falling due within one year
0 GBP2024-12-31
-541,504 GBP2024-03-06
Net Current Assets/Liabilities
4,500 GBP2024-12-31
216,556 GBP2024-03-06
Total Assets Less Current Liabilities
4,500 GBP2024-12-31
219,067 GBP2024-03-06
Equity
Called up share capital
4,500 GBP2024-12-31
4,500 GBP2024-03-06
Retained earnings (accumulated losses)
0 GBP2024-12-31
214,567 GBP2024-03-06
Equity
4,500 GBP2024-12-31
219,067 GBP2024-03-06
Average Number of Employees
02024-03-07 ~ 2024-12-31
32023-11-01 ~ 2024-03-06
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
0 GBP2024-12-31
64,110 GBP2024-03-06
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
0 GBP2024-12-31
61,599 GBP2024-03-06
Intangible Assets
Patents/Trademarks/Licences/Concessions
0 GBP2024-12-31
2,511 GBP2024-03-06
Trade Debtors/Trade Receivables
Current
0 GBP2024-12-31
286,031 GBP2024-03-06
Amounts Owed By Related Parties
4,500 GBP2024-12-31
Current
0 GBP2024-03-06
Other Debtors
Amounts falling due within one year
0 GBP2024-12-31
164,489 GBP2024-03-06
Debtors
Current, Amounts falling due within one year
4,500 GBP2024-12-31
450,834 GBP2024-03-06
Trade Creditors/Trade Payables
Current
0 GBP2024-12-31
78,123 GBP2024-03-06
Other Taxation & Social Security Payable
Current
0 GBP2024-12-31
398,421 GBP2024-03-06
Other Creditors
Current
0 GBP2024-12-31
64,960 GBP2024-03-06
Creditors
Current
0 GBP2024-12-31
541,504 GBP2024-03-06
Par Value of Share
Class 1 ordinary share
1 GBP2024-03-07 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1,500 shares2024-12-31
1,500 shares2024-03-06
Par Value of Share
Class 2 ordinary share
1 GBP2024-03-07 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
1,500 shares2024-12-31
1,500 shares2024-03-06
Par Value of Share
Class 3 ordinary share
1 GBP2024-03-07 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
1,500 shares2024-12-31
1,500 shares2024-03-06
Equity
Called up share capital
4,500 GBP2024-12-31
4,500 GBP2024-03-06
  • CENOTE PHARMA LIMITED
    Info
    Registered number 09910964
    102 High Street, Godalming GU7 1DS
    PRIVATE LIMITED COMPANY incorporated on 2015-12-10 (10 years 3 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-11-29
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 March 2026 and licensed under the Open Government Licence v3.0.